Combinative treatment of β-elemene and cetuximab is sensitive to KRAS mutant colorectal cancer cells by inducing ferroptosis and inhibiting epithelial-mesenchymal transformation

Background and Purpose: RAS mutations limit the effectiveness of anti-epidermal growth factor receptor (EGFR) monoclonal antibodies in combination with chemotherapy for metastatic colorectal cancer (mCRC) patients. Therefore, new cell death forms have focused on identifying indirect targets to inhib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Chen, Peng, Li, Xuejie, Zhang, Ruonan, Liu, Shuiping, Xiang, Yu, Zhang, Mingming, Chen, Xiaying, Pan, Ting, Yan, Lili, Feng, Jiao, Duan, Ting, Wang, Da, Chen, Bi, Jin, Ting, Wang, Wengang, Chen, Liuxi, Huang, Xingxing, Zhang, Wenzheng, Sun, Yitian, Li, Guohua, Kong, Lingpan, Chen, Xiaohui, Li, Yongqiang, Yang, Zuyi, Zhang, Qin, Zhuo, Lvjia, Sui, Xinbing, Xie, Tian
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7163451/
https://ncbi.nlm.nih.gov/pubmed/32308771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.44705
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados